Micell Technologies
Micell's supercritical fluid technology is used in applying a polymer and drug coating to a substrate (e.g., a stent platform) while preserving the crystalline integrity of the drug during the coating process. Fusing the polymer - applied using supercritical fluid technology - and the dry crystalline form of the drug creates a smooth, uniform, well-adhered drug-delivery formulation on the substrate and could be an enabling core technology for broad medical device and biopharmaceutical applications. Early aspects of this solvent-free coating technology were developed in conjunction with Pacific Northwest National Laboratory, a U.S. Department of Energy laboratory managed by Battelle Memorial Institute.
About Micell Technologies
Estimated Revenue
$50M-$100MEmployees
11-50Funding / Mkt. Cap
$119MCategory
Industry
Medical DevicesLocation
City
DurhamState
North CarolinaCountry
United StatesMicell Technologies
Find your buyer within Micell Technologies